Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

Míreanna comhchosúla

• Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
  de réir: Hill, Andrew, et al.
  Foilsithe / Cruthaithe: (2016)
• Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
  de réir: Andrew Hill, et al.
  Foilsithe / Cruthaithe: (2016)
• Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
  de réir: Hill, Andrew, et al.
  Foilsithe / Cruthaithe: (2017)
• Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
  de réir: Hill, Andrew, et al.
  Foilsithe / Cruthaithe: (2015)
• Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
  de réir: Melissa Barber, et al.
  Foilsithe / Cruthaithe: (2020)